These findings in the independent dataset suggest that the expression of ALDH1A1, LGALS3 and LGALS3BP may be indicative of the aggressiveness of HCC, and thus its inherent propensity to recur post-transplant. Here, ALDH1A1 is linked to hepatocellular carcinoma.